How big is the PGx market | Size, Share & Insights 2032

What is the PGx Market Size?

The market is witnessing robust growth due to the increasing adoption of precision medicine, integration of PGx testing into clinical workflows, and advancements in genomic technologies such as next-generation sequencing (NGS) and PCR. The ability of PGx to guide drug selection and dosage based on an individual’s genetic profile is transforming treatment protocols in oncology, cardiology, psychiatry, and infectious diseases.

Major Growth Factors of the PGx Market

• Rising adoption of personalized medicine and tailored therapeutic approaches
• Expansion of PGx applications across oncology, neurology, cardiology, and infectious diseases
• Advancements in genomic technologies (NGS, PCR, microarrays) improving speed and accuracy
• Supportive regulatory frameworks encouraging the inclusion of PGx data in drug labeling
• Growing awareness of adverse drug reactions and the role of PGx in minimizing them
• Increasing healthcare investments in genetic testing infrastructure
• Integration of AI and bioinformatics for enhanced PGx interpretation and clinical decision support
• Growing reimbursement coverage for pharmacogenomic tests in certain regions

PGx Market Trends

The PGx Market is experiencing increased demand for multi-gene panel testing, AI-assisted interpretation tools, and integration of PGx results into electronic health records for point-of-care decision-making. The use of NGS-based platforms is expanding due to their ability to deliver high-throughput and comprehensive data. There is also a shift toward direct-to-consumer PGx testing, enabling patients to access genetic insights without intermediary clinical visits.

Emerging Developments in the PGx Market

The PGx market is evolving with strategic collaborations between diagnostic companies, pharmaceutical manufacturers, and healthcare providers to develop integrated PGx solutions. Companies are investing in AI-based analytics for genotype–phenotype correlation and in expanding test menus beyond oncology. Technological innovations in point-of-care genetic testing are reducing turnaround times from weeks to hours.

List of Leading Companies in the PGx Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1.Illumina, Inc.

Leader in sequencing and array-based technologies widely adopted in PGx testing.

2.Thermo Fisher Scientific Inc.

Provides advanced genomic testing instruments, reagents, and bioinformatics solutions for PGx.

3.QIAGEN N.V.

Specializes in molecular diagnostics and sample-to-insight solutions tailored for pharmacogenomics.

4.F. Hoffmann-La Roche Ltd

Global healthcare leader with a strong portfolio in diagnostics and personalized medicine.

5.Eurofins Scientific SE

Offers a broad range of clinical and genomic testing services including pharmacogenomics.

6.Myriad Genetics, Inc.

Specializes in genetic testing services, including multi-gene PGx panels for various therapeutic areas.

How big is the PGx market : FAQ's